녹십자

006280KOSPI

55.8 / 100

Reference Date: 2026-09-08

Financial Score20.0 / 40

News Sentiment19.8 / 25

Momentum6.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Slightly down 2.0% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

LG Chem is a pharmaceutical company specializing in blood products and vaccines, with 2025 consolidated sales reaching 19.9 trillion won, a 18.54% increase from the previous year. Key products include ALYGLO, successfully launched in the U.S. market, the WHO-certified chickenpox vaccine 'BariCella', and the hemophilia treatment 'Greenjin E' approved in China. The company is focused on global expansion through strategic products and innovation.

Number of Employees

2,351people

Average Salary

73.1M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.004.0Point

PBR

1.07Industry Average 1.204.0Point

In line with industry avg

ROE

-2.07Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

30.91Industry Average 100.006.5Point

Half of industry avg (excellent)

Trend 2023~20255.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲10.9% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲54.3% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -2.1% (declining, 3yr)

Detailed News Sentiment

37 totalPositive 30Neutral 4Negative 3Average Sentiment Score 79.3

Positive
GC녹십자, 고령층 독감백신 식약처서 임상 2·3상 승인
GC녹십자의 고령층 대상 독감백신 후보물질 GC3114B가 임상 2·3상 승인을 받음으로써 긍정적인 시장 반응 예상.
Positive
GC메디아이, 약국 대체조제 흐름 짚는 분석 솔루션 출시
GC메디아이의 AI 기반 대체조제 분석 솔루션 출시로 녹십자 관련 시장 내 혁신과 효율성 향상 기대.
Positive
GC녹십자, 고령층 고면역원성 독감백신 임상 2/3상 승인…백신 개발 ...
GC녹십자의 고면역원성 독감백신 후보물질 승인으로 고령층 시장 확대 기대.

Detailed Momentum

52-week position3.0Point

52w lower range (21%)

Current 127,300Won52-week high 180,30052-week low 113,200

1-month return2.0Point

1m -2% (flat)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral반기보고서 (2026.06)2026-08-14